Lilly’s Alzheimer’s super drug to be approved ‘any day’
DUBLIN: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…
DUBLIN: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…